Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture; Vestergaard P, Rejnmark L, Mosekilde L.. Calcif Tissue Int. 2006;79:76-83.

Long-term proton pump inhibitor therapy and risk of hip fracture; Yang YX, Lewis JD, Epstein S, Metz DC. JAMA 2006;296:2947-53.

Use of proton pump inhibitors and risk of osteoporosis-related fractures; Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. CMAJ 2008 Aug 12;179(4):319-26.

Proton Pump Inhibitors and Histamine-2 Receptor Antagonists are Associated with Hip Fractures among At-Risk Patients; Corley, D.A., Kubo, A., Zhao, W., Quesenberry, C., Gastroenterology (2009), doi:10.1053/j.gastro.2010.03.055.

Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women; Gray SL, LaCroix AZ, Larson J, Robbins J, Cauley JA, Manson JE, Chen Z., Arch Intern Med 2010;170 (9):765-771.

Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults; Yu EW, Blackwell T, Ensrud KE, Hillier TA, Lane NE, Orwoll E, Bauer DC, et al, Calcif Tissue Int. 2008;83(4):251-259.

Popular Press - News releases:

FDA Warns of Fracture Risk with PPIs: High-Dose or Chronic Use May Increase Risk of Wrist, Hip, and Spine Breaks; ABC News, May 26, 2010

FDA: Some heartburn meds pose long-term fracture risk; CNN.com, May 26, 2010

FDA Warns of Fracture Risk With Popular Heartburn Drugs; Bloomberg Businessweek, May 26, 2010